zur Navigation zum Inhalt
 
Innere Medizin 1. September 2008

Striking response with bevacizumab and chemotherapy in a woman with heavily pretreated breast cancer

In pretreated breast cancer, encouraging therapy responses are regularly achieved by applying innovative therapies. We present here a case report of a woman with a 10-year history of breast cancer with continuous progression despite multiple therapies. Ultimately, ascitic effusion developed, massively disturbing her quality of life. A combination of bevacizumab and mitoxantrone/methotrexate chemotherapy led to a striking, response on liver metastasis and effusion generation, with great clinical benefit. Our case highlights previous observations that bevacizumab is beneficial in inhibiting the production of malignant effusion.

Zu diesem Thema wurden noch keine Kommentare abgegeben.

Mehr zum Thema

<< Seite 1 >>

Medizin heute

Aktuelle Printausgaben